To understand the molecular features that drive metastasis in uveal melanoma (UM) and assess the prognostic relevance of genetic alterations.
Approach:
Key Findings:
Mutations in BAP1, SF3B1, and EIF1AX correlate with high, intermediate, and low metastatic risk, respectively.
Gene expression profiling (15-GEP) is more predictive of metastasis-free and overall survival than individual driver mutations.
Small tumors are often classified as low-risk and show fewer high-risk genetic features, indicating they may represent an early evolutionary stage.
Interpretation:
Most UMs likely start as genetically simple, low-risk lesions that acquire mutations over time, emphasizing the importance of gene expression profiling in understanding tumor biology.
Limitations:
Longer follow-up is needed to confirm findings.
The study primarily focuses on a specific cohort, which may limit generalizability.
Conclusion:
The research advances the understanding of malignant transformation in UM and highlights the potential of integrated molecular testing for risk stratification.
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.
